Lidia
Ruiz Llorente
Profesor/a Ayudante Doctor/a
Hospital Universitario Príncipe de Asturias
Alcalá de Henares, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Príncipe de Asturias (4)
2022
-
Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity
Biomedicines, Vol. 10, Núm. 3
-
Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies
Current Oncology, Vol. 29, Núm. 4, pp. 2442-2453
2021
-
Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectives (Review)
Oncology Letters, Vol. 22, Núm. 5
2003
-
Expression of functionally active cannabinoid receptor CB1 in the human prostate gland
Prostate, Vol. 54, Núm. 2, pp. 95-102